The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
If the budget is dull that may not be good for May, as this government is in need of a "narrative" - other than the chaos of Brexit talks.
If you need to give an ancient structure a repair, there's a man in South Wales who will be happy to take your call.
Olivia's mum is to marry her fiance this weekend, and the couple are dedicating every detail of the day to Olivia.